[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364042-105":59,"doc-detail-364042-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","occult-breast-carcinoma-presenting-with-extensive-bone-involvement-in-the-absence-of-an-identifiable-primary-breast-lesion-a-case-report","Occult Breast Carcinoma Presenting with Extensive Bone Involvement in the Absence of an Identifiable Primary Breast Lesion - A Case Report","","Occult breast cancer (OBC) is a rare subtype of breast carcinoma defined by axillary or distant metastases without an identifiable primary breast lesion, making diagnosis difficult. This case report describes an atypical presentation with diffuse osteolytic bone metastases and axillary lymphadenopathy despite no clinically palpable, mammographically, or sonographically detectable breast lesion. Bone marrow biopsy and immunohistochemical analysis confirmed the diagnosis. Literature review identified only four prior OBC cases initially presenting with diffuse osseous metastases.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/occult-breast-carcinoma-presenting-with-extensive-bone-involvement-in-the-absence-of-an-identifiable-primary-breast-lesion-a-case-report/364042/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/occult-breast-carcinoma-presenting-with-extensive-bone-involvement-in-the-absence-of-an-identifiable-primary-breast-lesion-a-case-report/364042.png","ImageObject",300,407,{"name":92,"@type":93},"mieayamfan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What defines occult breast cancer in this report?","Question",{"text":112,"@type":113},"OBC is characterized by axillary or distant metastases without an identifiable primary breast lesion. This case involves metastasis with no detectable primary lesion on clinical exam or standard imaging.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the diagnosis established when no primary breast lesion was identifiable?",{"text":117,"@type":113},"The diagnosis was established using bone marrow biopsy and immunohistochemical analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is this case clinically important for patients with metastatic cancer of unknown primary?",{"text":121,"@type":113},"It emphasizes maintaining a high index of suspicion for OBC in metastatic adenocarcinoma of unknown primary origin with diffuse skeletal involvement, and highlights hormone receptor biology that may support endocrine-based durable disease control.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364042,1790230473,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Case Report  \n\n| Occult Breast Carcinoma Presenting with Extensive Bone Involvement in the Absence of an Identifiable Primary Breast Lesion: A Case Report | Journal of Investigative Medicine High Impact Case Reports\u003Cbr>Volume 14: 1–11 © 2026 American Federation for Medical Research\u003Cbr>DOI: 10. 1177/23247096261481669\u003Cbr>[journals.sagepub.com/home/hic](journals.sagepub.com/home/hic)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Shengmin Huang1, Amulya Bellamkonda2, M. Rashid Chaudhry3, Richard Wu4, and\u003Cbr>Jen C. Wang2 \u003Cbr>Abstract\u003Cbr>Occult breast cancer (OBC) is a rare and diagnostically challenging subtype of breast carcinoma characterized by axillary or distant metastases without an identifiable primary breast lesion. We report an unusual presentation of OBC in a patient with diffuse osteolytic bone metastases and axillary lymphadenopathy in the absence of clinically palpable, mammographically, or sonographically detectable breast lesions. The diagnosis was established through bone marrow biopsy and immunohistochemical analysis. Review of the literature identified only four previously reported cases of OBC initially presenting with diffuse osseous metastases, three of which were hormone receptor–positive. This case highlights the importance of maintaining a high index of suspicion for OBC in patients with metastatic adenocarcinoma of unknown primary origin with diffuse skeletal involvement. Furthermore, it underscores the distinct biologic behavior of hormone receptor–positive breast cancer, which preferentially metastasizes to bone and may achieve durable disease control with endocrine-based therapy, allowing selected patients to avoid cytotoxic chemotherapy.\u003Cbr>Keywords\u003Cbr>occult breast cancer, bone marrow metastasis, diffuse osseous metastases, invasive ductal carcinoma, hormone receptor– positive breast cancer\u003Cbr>Received: 11 June 2026; Revised: 24 July 2026; Accepted: 10 August 2026\u003Cbr>Introduction\u003Cbr>Breast cancer remains a major public health concern, with a lifetime incidence of 12.9%, meaning approximately one in eight women in the United States will develop breast cancer during their lifetime.1 It is the second leading cause of cancer-related death among women, accounting for more than 41,000 deaths annually and approximately 15% of all cancer-related deaths in women in the United States.2 Advances in early detection and multimodal treatment have significantly improved outcomes for patients with localized disease. |  |\n| 1Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA\u003Cbr>2Division of Hematology/Oncology, Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA 3Department of Surgery, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA\u003Cbr>4Division of Pathology, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA\u003Cbr>Corresponding author:\u003Cbr>Jen C. Wang, MD, Division of Hematology/Oncology, Brookdale University Hospital Medical Center, 1 Brookdale Plz, Brooklyn, NY 11212, USA.\u003Cbr>Email: [jcwang0005@gmail.com](jcwang0005@gmail.com) |  |\n\nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nDespite these advances, metastatic breast cancer continues to carry a poor prognosis. Approximately 20-30% of patients develop distant metastases following initial diagnosis and treatment, and nearly 90% of breast cancer-related deaths are attributable to metastatic disease.3 The axillary lymph nodes are the most common initial site of breast cancer m","cbCaigvBNTDNhHeN","https://ap.wps.com/l/cbCaigvBNTDNhHeN","pdf",2718858,11,"English","# Abstract\n# Keywords\n# Introduction\n# Case Presentation","[{\"question\":\"What defines occult breast cancer in this report?\",\"answer\":\"OBC is characterized by axillary or distant metastases without an identifiable primary breast lesion. This case involves metastasis with no detectable primary lesion on clinical exam or standard imaging.\"},{\"question\":\"How was the diagnosis established when no primary breast lesion was identifiable?\",\"answer\":\"The diagnosis was established using bone marrow biopsy and immunohistochemical analysis.\"},{\"question\":\"Why is this case clinically important for patients with metastatic cancer of unknown primary?\",\"answer\":\"It emphasizes maintaining a high index of suspicion for OBC in metastatic adenocarcinoma of unknown primary origin with diffuse skeletal involvement, and highlights hormone receptor biology that may support endocrine-based durable disease control.\"}]","Occult Breast Carcinoma Presenting with Extensive Bone Involvement in the Absence of an Identifiable Primary Breast Lesion - A Case Report | PDF",1790155274,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9380e8d8f20220f999eed3cb1335d9b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd3c9474f5d6c8ae57da44f7b6de5366.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e48c61037fc16a00d5de7c480f8da0a.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c63608d5c26106635469ab9db95aa9af.webp",980,1306]